Neuromodulation is the use of medications or technology to alter the activity of neurons to reduce symptoms, improve functioning, and improve quality of life. Over the past year, there have been some changes to the neuromodulation program here at Weill Cornell Medicine and NewYork-Presbyterian.

Dr. Dennis Popeo will discuss uses for electroconvulsive therapy beyond mood disorders. Dr. Roy Smetana will discuss the current state of research on the use of ketamine to treat refractory depression and suicidal ideation. Dr. Benjamin Zebley will discuss TMS.

After the presentations, the three presenters will field questions about access to these services and other topics of interest regarding neuromodulation. Please view the continuing education flyer for more information.